A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors
Authors
Keywords
Dasatinib, Gemcitabine, Pancreatic cancer, Phase 1, Advanced solid tumors
Journal
INVESTIGATIONAL NEW DRUGS
Volume 31, Issue 4, Pages 918-926
Publisher
Springer Nature
Online
2012-11-19
DOI
10.1007/s10637-012-9898-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes in Biomarkers of Inflammation and Angiogenesis During Androgen Deprivation Therapy for Prostate Cancer
- (2012) P. J. Saylor et al. ONCOLOGIST
- Src: a potential target for the treatment of triple-negative breast cancer
- (2011) D. Tryfonopoulos et al. ANNALS OF ONCOLOGY
- Combined Blockade of Src Kinase and Epidermal Growth Factor Receptor with Gemcitabine Overcomes STAT3-Mediated Resistance of Inhibition of Pancreatic Tumor Growth
- (2011) N. S. Nagaraj et al. CLINICAL CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
- (2011) Peter S. Hammerman et al. Cancer Discovery
- New emerging drugs targeting the genomic integrity and replication machinery in ovarian cancer
- (2010) Ansgar Brüning et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- A phase 2 trial of dasatinib in advanced melanoma
- (2010) Harriet M. Kluger et al. CANCER
- Dasatinib: A potent SRC inhibitor in clinical development for the treatment of solid tumors
- (2010) John Araujo et al. CANCER TREATMENT REVIEWS
- Dasatinib Inhibits the Development of Metastases in a Mouse Model of Pancreatic Ductal Adenocarcinoma
- (2010) Jennifer P. Morton et al. GASTROENTEROLOGY
- Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells
- (2010) Michal Mego et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Study of Dasatinib in Patients With Advanced Non–Small-Cell Lung Cancer
- (2010) Faye M. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
- (2010) Lars Petter Jordheim et al. LANCET ONCOLOGY
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors
- (2009) G. D. Demetri et al. CLINICAL CANCER RESEARCH
- Cancer Therapy Beyond Apoptosis: Autophagy and Anoikis as Mechanisms of Cell Death
- (2009) Jodi M. Coates et al. JOURNAL OF SURGICAL RESEARCH
- Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
- (2008) S. I. Park et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now